1. Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life. (16th June 2009) Authors: Jeppesen, P. B.; Lund, P.; Gottschalck, I. B.; Nielsen, H. B.; Holst, J. J.; Mortensen, J.; Poulsen, S. S.; Quistorff, B.; Mortensen, P. B. Other Names: Geboes Karel Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life. (16th June 2009) Authors: Jeppesen, P. B.; Lund, P.; Gottschalck, I. B.; Nielsen, H. B.; Holst, J. J.; Mortensen, J.; Poulsen, S. S.; Quistorff, B.; Mortensen, P. B. Other Names: Geboes Karel Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function. (3rd August 2009) Authors: Jeppesen, P. B.; Lund, P.; Gottschalck, I. B.; Nielsen, H. B.; Holst, J. J.; Mortensen, J.; Poulsen, S.S.; Quistorff, B.; Mortensen, P. B. Other Names: Geboes Karel Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗